Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4567888
Max Phase: Preclinical
Molecular Formula: C28H25N3O5
Molecular Weight: 483.52
Molecule Type: Unknown
Associated Items:
ID: ALA4567888
Max Phase: Preclinical
Molecular Formula: C28H25N3O5
Molecular Weight: 483.52
Molecule Type: Unknown
Associated Items:
Canonical SMILES: COc1cc(C(=O)c2c[nH]c(-c3c[nH]c4ccc(OCc5ccccc5)cc34)n2)cc(OC)c1OC
Standard InChI: InChI=1S/C28H25N3O5/c1-33-24-11-18(12-25(34-2)27(24)35-3)26(32)23-15-30-28(31-23)21-14-29-22-10-9-19(13-20(21)22)36-16-17-7-5-4-6-8-17/h4-15,29H,16H2,1-3H3,(H,30,31)
Standard InChI Key: JFHVUEHDNZOJAE-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 483.52 | Molecular Weight (Monoisotopic): 483.1794 | AlogP: 5.39 | #Rotatable Bonds: 9 |
Polar Surface Area: 98.46 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 2 |
#RO5 Violations: 1 | HBA (Lipinski): 8 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 9.97 | CX Basic pKa: 3.95 | CX LogP: 4.92 | CX LogD: 4.92 |
Aromatic Rings: 5 | Heavy Atoms: 36 | QED Weighted: 0.27 | Np Likeness Score: -0.19 |
1. Wang Q, Arnst KE, Wang Y, Kumar G, Ma D, White SW, Miller DD, Li W, Li W.. (2019) Structure-Guided Design, Synthesis, and Biological Evaluation of (2-(1H-Indol-3-yl)-1H-imidazol-4-yl)(3,4,5-trimethoxyphenyl) Methanone (ABI-231) Analogues Targeting the Colchicine Binding Site in Tubulin., 62 (14): [PMID:31251599] [10.1021/acs.jmedchem.9b00706] |
Source(1):